Celgene (CELG) on Watch Amid Takeover Chatter

September 22, 2016 10:34 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Celgene (NASDAQ: CELG) was in focus Thursday amid takeover chatter involving Novartis (NYSE: NVS).

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Rumors, Trader Talk

Add Your Comment